Piper Sandler Maintains Overweight on Helmerich & Payne, Lowers Price Target to $47-Report released on 12th Nov 2023
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Luke Lemoine has maintained an Overweight rating on Helmerich & Payne (NYSE:HP) but reduced the price target from $51 to $47.

November 13, 2023 | 9:44 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Piper Sandler has maintained an Overweight rating on Helmerich & Payne but lowered the price target from $51 to $47, indicating a positive outlook but with reduced expectations.
While the Overweight rating suggests that Piper Sandler is optimistic about Helmerich & Payne's future performance, the reduction in the price target may reflect a tempered expectation for the stock's growth potential in the short term. This could lead to mixed reactions in the market, with some investors seeing the lowered target as a sign of caution, while others may focus on the continued positive rating.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100